9 terminated. 9 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Terminated 9 |
| Phase 1 | 2 | Terminated 2 |
Follow Hematologic Malignancies: new trials by email Literature Review of Hematologic Malignancies trials Research Report on Hematologic Malignancies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BGJ398 for Patients With Tumors With FGFR Genetic Alterations BGJ398 - Solid Tumor, Hematologic Malignancies | Phase 2 | Terminated | Novartis Pharmaceuticals | 84 | 2014-07-24 | 2019-06-18 |
| LGX818 for Patients With BRAFV600 Mutated Tumors LGX818 - Solid Tumor, Hematologic Malignancies | Phase 2 | Terminated | Pfizer | 12 | 2014-01-14 | 2021-03-26 |
| A Study of Haploidentical Bone Marrow Transplant for Patients With Hematologic Malignancies Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant - Hematologic Malignancies | Phase 2 | Terminated | University of California, San Diego | 10 | 2012-09-21 | 2025-11-10 |
| Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation Haploidentical Transplant, Fludarabine, Busulfan - Hematologic Malignancies | Phase 2 | Terminated | University of Illinois at Chicago | 3 | 2012-08-30 | 2020-02-25 |
| The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies. ProHema-CB, Untreated CB - Hematologic Malignancies | Phase 2 | Terminated | Fate Therapeutics | 62 | 2012-07-01 | 2021-11-30 |
| Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies Fludarabine, Busulfan, Thymoglobulin - Hematologic Malignancies | Phase 2 | Terminated | University of Virginia | 6 | 2012-01-01 | 2014-02-11 |
| Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps Fludarabine, Thiotepa, Total Body Irradiation (TBI) - Hematologic Malignancies, Acute Leukemia | Phase 1 / Phase 2 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 8 | 2011-04-01 | 2025-05-31 |
| Anidulafungin in Patients With Hematologic Malignancies Anidulafungin - Hematologic Malignancies | Phase 2 | Terminated | Elisabethinen Hospital | 10 | 2009-10-01 | 2012-03-02 |
| Stem Cell Transplant for Hematologic Diseases Campath 1H, Fludarabine, Stem Cell Transplant - Hematologic Malignancies | Phase 1 / Phase 2 | Terminated | Baylor College of Medicine | 27 | 2000-08-01 | 2016-11-07 |
Hematologic Neoplasms (9) · Hodgkin Disease (2) · Lymphoma, Non-Hodgkin (2) · Myelodysplastic Syndromes (2) · Candidiasis, Invasive (1) · Invasive Fungal Infections (1) · Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Myeloproliferative Disorders (1) · Neoplasms, Plasma Cell (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (9) · Hemic and Lymphatic Diseases (9) · Neoplasms (9) · Neoplasms by Site (9) · Bone Marrow Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoproliferative Disorders (2) · Neoplasms by Histologic Type (2) · Bacterial Infections and Mycoses (1) · Candidiasis (1) · Chronic Disease (1) · Disease Attributes (1)
Whole-Body Irradiation (4) · fludarabine (4) · Busulfan (2) · Cyclophosphamide (2) · fludarabine phosphate (2) · Alemtuzumab (1) · Anidulafungin (1) · Cyclosporine (1) · Hematopoietic Stem Cell Transplantation (1) · Melphalan (1) · Radiotherapy (1) · Stem Cell Transplantation (1) · Tacrolimus (1) · Thiotepa (1) · encorafenib (1)
Baylor College of Medicine (1) · Elisabethinen Hospital (1) · Fate Therapeutics (1) · Novartis Pharmaceuticals (1) · Pfizer (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · University of California, San Diego (1) · University of Illinois at Chicago (1) · University of Virginia (1)
United States (8) · Austria (1)
Amer M Beitinjaneh, MD (1) · Caitlin Caitlin, MD (1) · Chris Storgard, M.D. (1) · Dolores Grosso, DNP, CRNP (1) · George Carrum, MD (1) · Michael Girschikofsky, MD (1) · Neal Flomenberg, MD (1) · Pritesh Patel, MD (1)
2009 (1)